» Articles » PMID: 19369675

Risks of Long-acting Beta-agonists in Achieving Asthma Control

Overview
Journal N Engl J Med
Specialty General Medicine
Date 2009 Apr 17
PMID 19369675
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.

Slob E, Richards L, Vijverberg S, Longo C, Koppelman G, Pijnenburg M Pediatr Allergy Immunol. 2021; 32(6):1197-1207.

PMID: 33706416 PMC: 8328929. DOI: 10.1111/pai.13494.


Therapeutic Effects of a Long-Acting Cholinergic Receptor Blocker, Tiotropium Bromide, on Asthma.

Zhang L, Huang G, Jin L, Han S Med Sci Monit. 2018; 24:944-950.

PMID: 29446377 PMC: 5822933. DOI: 10.12659/msm.907950.


The evidence on tiotropium bromide in asthma: from the rationale to the bedside.

Radovanovic D, Santus P, Blasi F, Mantero M Multidiscip Respir Med. 2017; 12:12.

PMID: 28484598 PMC: 5420159. DOI: 10.1186/s40248-017-0094-3.


Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Scichilone N, Braido F, Lavorini F, Levy M, Usmani O Drugs Aging. 2017; 34(5):321-330.

PMID: 28258535 DOI: 10.1007/s40266-017-0449-7.


Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy.

Altawalbeh S, Thorpe J, Thorpe C, Smith K Value Health. 2016; 19(5):537-43.

PMID: 27565270 PMC: 7961838. DOI: 10.1016/j.jval.2016.02.004.